Results 191 to 200 of about 79,681,589 (222)
Some of the next articles are maybe not open access.
Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 2005
Mice exposed to various stresses, especially restrained-stress, revealed the anxiogenic effect detected by the light-dark test. Under this condition, a remarkable decrease in [35S]GTPgammaS binding to membranes from the prefrontal cortex, amygdala and hypothalamus of restrained-stress mice stimulated by the selective 5-HT1A receptor agonist 5 ...
Minoru, Narita +5 more
openaire +1 more source
Mice exposed to various stresses, especially restrained-stress, revealed the anxiogenic effect detected by the light-dark test. Under this condition, a remarkable decrease in [35S]GTPgammaS binding to membranes from the prefrontal cortex, amygdala and hypothalamus of restrained-stress mice stimulated by the selective 5-HT1A receptor agonist 5 ...
Minoru, Narita +5 more
openaire +1 more source
The therapeutic potential of 5-HT1A receptors: a patent review
Expert Opinion on Therapeutic Patents, 2012The 5-HT(1A) receptors are implicated in mood disorders (anxiety, depression), in cognition, and in modulation of pain. Nearly 30 years of research in this field, there is still interest in developing new chemical entities capable of 5-HT(1A) receptor activation or blockade.This review article will highlight and review the research advances published ...
LACIVITA, ENZA +6 more
openaire +2 more sources
[Presynaptic 5-HT1A receptors in immunomodulation].
Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova, 2007It is shown that a selective agonist of 5-HT1A receptors 8-OH-DPAT in a low dose (0.1 mg/kg), which is known to affect mainly the presynaptic 5-HT1A receptors increased the immune response at the peak of reactions (the forth or fifth day after immunization with sheep red blood cells - SRBC) in CBA mice and Wistar rats. Treatment of the animals with the
S M, Davydova, G V, Idova
openaire +1 more source
CBD and the 5-HT1A receptor: A medicinal and pharmacological review
Biochemical PharmacologyCannabidiol (CBD), a phytocannabinoid, has emerged as a promising candidate for addressing a wide array of symptoms. It has the ability to bind to multiple proteins and receptors, including 5-HT1AR, transient receptor potential vanilloid 1 (TRPV1), and cannabinoid receptors.
Claire Alexander +4 more
openaire +2 more sources
Critical Care Management of Chimeric Antigen Receptor T-Cell Therapy Recipients
Ca-A Cancer Journal for Clinicians, 2022Sandrine Valadè +2 more
exaly
The 5-HT1A receptor and recognition memory
Behavioural Brain Research, 2005Nikolaos Pitsikas +3 more
openaire +1 more source
Epigenetic Regulation of Toll-Like Receptor Signaling: Implications for Cancer Development
Medical Epigenetics, 2013Sherine F Elsawa
exaly

